ALB and breast carcinoma: Recently, we developed hybrid eumelanin–silver NPs (MelaSil_Ag) functionalized with human serum albumin (HSA) as a new kind of nanoprobe (MelaSil_Ag-HSA NPs) able to target breast cancer cells via HSA–SPARC interaction [18].